Summit Clinical Research is an Integrated Research Organization that specializes in Non-Alcoholic Steatohepatitis (NASH) research. Founded in 2018, the company has a strong focus on Therapeutically Focused Research, reflected in its slogan, "Defining the Future of Therapeutically Focused Research." With its headquarter in the United States, Summit brings together experienced research sites to drive advancements in the Biotechnology and Health Care industries.
Currently, there are no records of recent investments or identified investors. Nevertheless, Summit Clinical Research stands as a compelling opportunity for venture capitalists looking to invest in cutting-edge research and development in the healthcare sector.